EC Paediatrics

Angioedema is a common symptom with different etiologies, diagnostic orientation is based on the associated signs. The most common are histamines, non-IgE-mediated, mild and often associated with hives. Anaphylaxis angioedema and bradykinin angioedema are rare but potentially severe due to upper airway involvement. We report the case of a 14-year-old patient with a history of bilateral orbital swelling associated with deep urticaria, and a brother followed for angioedema. Presenting with bilateral palpebral and jugal edema, associated with urticaria tasks in the trunk and back. The diagnosis of histamine angioedema was made and confirmed by the response to corticosteroids and antihistamines, and a biological assessment ruling out differential diagnoses. Treatment was based on crisis management and the implementation of substantive treatment for recurrent and disabling seizures. Education measures associated with this drug treatment are also essential.

Keywords: Angioedema; Histamine; Bradykinin; Children; Antihistamine

1. Pattanaik D and Lieberman JA. “Pediatric Angioedema”. Current Allergy and Asthma Reports 9 (2017): 60.
2. Zuberbier T., et al. “Epidemiology of urticaria: a representative cross-sectional population survey”. Clinical and Experimental Dermatology 8 (2010): 869-873.
3. Boccon-Gibod I and Bouillet L. “Angioedema and urticaria”. Annales de Dermatologie et de Vénéréologie 3 (2014): S586-S595.
4. Hacard F., et al. “Histaminergic angioedema and chronic urticaria”. La Presse Médicale 1 (2015): 37-42.
5. Zuberbier T., et al. “The Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update”. Allergy7 (2018): 1393-1414.
6. B Floccard., et al. “Bradykinin angioedema”. Rare diseases in resuscitation (2010): 263-274.
7. Williams PV. “Pharmacologic management of chronic urticaria in pediatric patients: the gap between guidelines and practice”. Paediatric Drugs 1 (2020): 21-28.